Today: 21 May 2026
Browse Category

NYSE:UNH 16 December 2025 - 30 December 2025

UnitedHealth (UNH) stock slips after hours as UnitedHealthcare delays remote monitoring policy

UnitedHealth (UNH) stock slips after hours as UnitedHealthcare delays remote monitoring policy

UnitedHealth Group shares slipped 0.9% to $328.94 in after-hours trading Monday after its UnitedHealthcare unit postponed a policy tightening reimbursement for remote physiologic monitoring. The move follows scrutiny of remote monitoring costs and billing practices. A federal judge in Idaho also granted UnitedHealthcare a preliminary injunction blocking state enforcement of certain Medicare Advantage marketing rules.
30 December 2025
·
UnitedHealth stock slips as WSJ flags Optum mail-order refills ahead of 2026 guidance

UnitedHealth stock slips as WSJ flags Optum mail-order refills ahead of 2026 guidance

UnitedHealth shares slipped 0.2% to $331.19 after a Wall Street Journal report said insurer-owned mail-order pharmacies, including UnitedHealth’s, dispensed billions in excess prescription drugs to Medicare patients. The Journal found mail-order pharmacies made up 9% of Medicare prescriptions but 37% of excess drugs from 2021 to 2023. Investors await UnitedHealth’s Jan. 27 results and 2026 guidance.
29 December 2025
Healthcare Stocks Today: Weekend Headlines, 2026 Themes, and What to Watch Before Monday’s Open

Healthcare Stocks Today: Weekend Headlines, 2026 Themes, and What to Watch Before Monday’s Open

U.S. equity markets are closed for the weekend. Healthcare stocks face new catalysts for Monday, including policy scrutiny after a Wall Street Journal report on Medicare drug waste tied to UnitedHealth, Humana, and CVS Health, and Johnson & Johnson halting a mid-stage eczema drug trial. The S&P 500 remains near 7,000 as investors rotate into sectors with moderate valuations.
28 December 2025
··
UnitedHealth Group (UNH) Stock Today: Weekend Market Close, Fresh Headlines, Analyst Targets, and What to Watch Before Monday’s Open

UnitedHealth Group (UNH) Stock Today: Weekend Market Close, Fresh Headlines, Analyst Targets, and What to Watch Before Monday’s Open

UnitedHealth Group shares closed Friday at $331.83, up 1.3% on low volume before the U.S. market shut for the holiday. Barron’s highlighted investor focus on the company’s upcoming 2026 guidance after Medicare Advantage disruptions. The Wall Street Journal reported scrutiny of insurer-owned pharmacies, including UnitedHealth, over excess drug dispensing to Medicare patients.
28 December 2025
UnitedHealth Group (UNH) Stock: What to Know Before the U.S. Market Opens on Dec. 26, 2025

UnitedHealth Group (UNH) Stock: What to Know Before the U.S. Market Opens on Dec. 26, 2025

UnitedHealth Group shares last traded at $327.58 before the Christmas break, with markets reopening Dec. 26. The company faces ongoing federal scrutiny over Medicare billing and is implementing 23 operational changes after external audits, including reviews of its HouseCalls and Optum Rx units. Investors remain focused on regulatory risk and the pace of operational reforms.
26 December 2025
·
UnitedHealth (UNH) Stock After-Hours Today (Dec. 24, 2025): What’s Driving the Move and What to Watch Before the Next Market Open

UnitedHealth (UNH) Stock After-Hours Today (Dec. 24, 2025): What’s Driving the Move and What to Watch Before the Next Market Open

UnitedHealth Group closed at $327.58, up 0.86% in a shortened Christmas Eve session, then slipped to $327.17 after hours. Trading volume was about 2.84 million shares. Philadelphia filed a lawsuit naming OptumRx, UnitedHealth’s pharmacy benefit manager, over alleged insulin price-fixing. U.S. equity markets will be closed Dec. 25 for Christmas.
24 December 2025
·
UnitedHealth Group (UNH) Stock After Hours Today (23.12.2025): Latest News, Forecasts, and What to Watch Before the Market Opens Tomorrow

UnitedHealth Group (UNH) Stock After Hours Today (23.12.2025): Latest News, Forecasts, and What to Watch Before the Market Opens Tomorrow

UnitedHealth Group shares closed Tuesday near $324.80 and edged up to about $325.28 after hours, with light volume ahead of the holiday. The stock is down roughly 35.8% year-to-date, making it the Dow’s worst performer in 2025. No major company news was released late Tuesday. CEO Stephen Hemsley disclosed a 55,000-share gift in an SEC filing.
24 December 2025
·
UnitedHealth (UNH) Stock News Today (Dec. 23, 2025): Audits, Washington Policy Pressure, and Analyst Price Targets

UnitedHealth (UNH) Stock News Today (Dec. 23, 2025): Audits, Washington Policy Pressure, and Analyst Price Targets

UnitedHealth Group traded near $325 Tuesday, little changed as investors assessed new operational reforms and ongoing federal scrutiny. The company released initial findings from external audits and outlined a 23-point action plan targeting Medicare Advantage billing and internal processes. CEO Stephen Hemsley said most reforms should be completed by end-2025, with all done by Q1 2026.
23 December 2025
UnitedHealth Group (UNH) Stock After Hours Today (Dec. 22, 2025): Latest News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth Group (UNH) Stock After Hours Today (Dec. 22, 2025): Latest News, Analyst Forecasts, and What to Watch Before Tuesday’s Open

UnitedHealth Group shares closed Monday at $325.16, down 0.69%, underperforming the S&P 500’s 0.64% gain. After-hours trading saw little movement, with prices hovering just below the close. Investors remain cautious amid ongoing regulatory scrutiny and questions about the company’s operational turnaround. Trading volumes were thin ahead of the holiday.
23 December 2025
·
UnitedHealth Group (UNH) Stock News, Forecasts and Analysis for Dec. 22, 2025: Independent Reviews, DOJ Scrutiny, and 2026 Guidance in Focus

UnitedHealth Group (UNH) Stock News, Forecasts and Analysis for Dec. 22, 2025: Independent Reviews, DOJ Scrutiny, and 2026 Guidance in Focus

UnitedHealth Group shares traded near $325.48 on Dec. 22, down slightly from the previous close. The company released initial findings from independent reviews of its Medicare Advantage, care management, and Optum Rx operations, citing broadly sound practices but highlighting areas for improved oversight. UnitedHealth plans to complete most recommended changes by the end of 2025.
22 December 2025
·
UnitedHealth (UNH) Stock: Key Audit Updates, DOJ Risks, Earnings Outlook and Analyst Forecasts Before the Market Opens Dec. 22, 2025

UnitedHealth (UNH) Stock: Key Audit Updates, DOJ Risks, Earnings Outlook and Analyst Forecasts Before the Market Opens Dec. 22, 2025

UnitedHealth closed Friday at $327.42, down about one-third over the past year and near the lower end of its 52-week range. The company said it will make major operational changes after external audits of its health services and pharmacy benefit manager units, citing documentation issues in Medicare Advantage programs. Markets face thin holiday trading, with NYSE and Nasdaq closing early Dec. 24 and shut Dec. 25.
22 December 2025
··
UnitedHealth Group (UNH) Stock Week Ahead: Audit Overhaul, Trump’s Insurer Price Talks, and ACA Subsidy Deadline Drive the Outlook

UnitedHealth Group (UNH) Stock Week Ahead: Audit Overhaul, Trump’s Insurer Price Talks, and ACA Subsidy Deadline Drive the Outlook

UnitedHealth Group stock last traded near $327 ahead of the holiday-shortened week, with investors watching regulatory headlines and ongoing scrutiny of Medicare Advantage practices. Shares dropped nearly 10% intraday after former President Trump called for lower insurer prices before recovering. The company is implementing 23 operational changes following outside audits, with most set for completion by end-2025.
21 December 2025
·
UnitedHealth Group Stock (UNH) After Hours: Trump Premium Comments, New Audit “Action Plans,” and What to Watch Before the Next Market Open

UnitedHealth Group Stock (UNH) After Hours: Trump Premium Comments, New Audit “Action Plans,” and What to Watch Before the Next Market Open

UnitedHealth shares closed near $327 Friday after volatile trading triggered by President Trump’s call for insurers to cut prices and the company’s release of 23 operational action plans. The stock swung between $326.1 and $334.6 before settling just below its opening price, then edged slightly lower after hours.
20 December 2025
·
UnitedHealth Group Incorporated Stock (NYSE: UNH) News Today: Audit-Driven Overhaul, OptumRx Shift, and 2026 Forecasts (Dec. 19, 2025)

UnitedHealth Group Incorporated Stock (NYSE: UNH) News Today: Audit-Driven Overhaul, OptumRx Shift, and 2026 Forecasts (Dec. 19, 2025)

UnitedHealth Group shares rose 1.55% to $333.22 Friday after the company announced operational changes following external audits of its health services and pharmacy benefit units. CEO Stephen Hemsley said more than half of 23 action plans will be finalized by year-end, with all completed by Q1 2026. Audits cited documentation gaps in HouseCalls and called for more automation at OptumRx. UnitedHealth denies wrongdoing amid ongoing DOJ scrutiny.
19 December 2025
·
UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group Stock (UNH) News Today, Dec. 18, 2025: Policy Risk, Optum Rx Changes, and Wall Street Forecasts

UnitedHealth Group shares traded around $326–$327 midday on Dec. 18, 2025, after a volatile year marked by a 32.6% price drop. A Reuters report highlighted possible sharp ACA premium hikes in 2026 and UnitedHealth’s warning that enrollment could fall by two-thirds if subsidies are not extended. Legislative uncertainty around ACA subsidies remains high.
18 December 2025
·
UnitedHealth Group (UNH) Stock After Hours Today: Key Headlines, Analyst Forecasts, and What to Watch Before the Market Opens Dec. 18, 2025

UnitedHealth Group (UNH) Stock After Hours Today: Key Headlines, Analyst Forecasts, and What to Watch Before the Market Opens Dec. 18, 2025

UnitedHealth Group shares closed at $331.51, down 0.81%, and slipped further to $330.19 in after-hours trading Wednesday. The drop followed a Guardian investigation into its nursing home program and a broader market decline, with the S&P 500 falling 1.16%. Trading volume was about half the three-month average. UnitedHealth denied wrongdoing in response to the report’s allegations.
18 December 2025
·
1 … 5 6 7 8 9 10

Stock Market Today

  • Why Investors Should Sell Rapid7 Amid Declining Metrics and Consider Alternatives
    May 21, 2026, 3:54 PM EDT. Rapid7 (RPD) shares have plunged nearly 50% since November 2025, raising concerns among investors. Key red flags include stagnant billings at $199.2 million, indicating customer acquisition struggles amid stiff competition. The firm's customer acquisition cost (CAC) payback period turned negative this quarter, suggesting sales efforts are not recouping expenses efficiently. Additionally, Rapid7's GAAP operating margin shrank by 1.7 percentage points over two years to 1.3%, questioning profitability despite revenue growth. Trading at 0.5× forward price-to-sales, the stock appears cheap but poses significant downside risks given weak fundamentals. Analysts advise caution and suggest considering higher quality alternatives before investing in Rapid7.

Latest articles

RBC Stock Heads Toward Earnings With Tougher Weeks Ahead

RBC Stock Heads Toward Earnings With Tougher Weeks Ahead

21 May 2026
Royal Bank of Canada shares climbed 1.46% to C$261.09 in Toronto Thursday, outpacing the S&P/TSX Composite ahead of its May 28 earnings release. Visible Alpha estimates see net income up 19% to C$5.4 billion. Analyst calls diverged, with BofA raising its price target and Raymond James downgrading the stock to neutral. RBC shares have gained nearly 49% over the past year.
Sandisk Stock Jumps Again as AI Demand Fuels Memory Squeeze

Sandisk Stock Jumps Again as AI Demand Fuels Memory Squeeze

21 May 2026
Sandisk shares surged about 10% Thursday, trading at $1,533.00 by 2:52 p.m. EDT after management said NAND flash supply would stay tight. Citi raised its price target to $2,025. Western Digital and Micron also gained. Sandisk reported fiscal Q3 revenue of $5.95 billion, up 97% sequentially, with net income of $3.62 billion.
Spotify jumps after Universal AI deal, 2030 outlook

Spotify jumps after Universal AI deal, 2030 outlook

21 May 2026
Spotify shares rose 13.5% to $491.92 Thursday after announcing a new AI music licensing deal with Universal Music Group and unveiling growth targets at its investor day in New York. The company projected mid-teens annual revenue growth through 2030, gross margin of 35–40%, and operating margin above 20%. Spotify reported 761 million monthly active users in April.
Go toTop